Raluca Roxana Grigorescu

Dr. Raluca Roxana Grigorescu

gastroenterology, Sfanta Maria Clinical Hospital, Bucharest, Bucureşti, Romania
+1
orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 August 2024 in Life
Verified
Journal Article
Open access
RGRaluca Roxana Grigorescu
Raluca Roxana Grigorescu
IHIoana Alexandra Husar-Sburlan
Ioana Alexandra Husar-Sburlan
CGCristian Gheorghe
Cristian Gheorghe
Pancreatic adenocarcinoma is one of the most lethal types of gastrointestinal cancer despite the latest medical advances. Its incidence has continuously increased in recent years in developed countries. The location of the pancreas can result in the initial symptoms of neoplasia being overlooked, which can lead to a delayed diagnosis and a subsequent reduction in the spectrum of available therapeutic options. The role of modifiable risk factors in pancreatic cancer has been extensively studied in recent years, with smoking and alcohol consumption identified as key contributors. However, the few screening programs that have been developed focus exclusively on genetic factors, without considering the potential impact of modifiable factors on disease occurrence. Thus, fully understanding and detecting the risk factors for pancreatic cancer represents an important step in the prevention and early diagnosis of this type of neoplasia. This review reports the available evidence on different risk factors and identifies the areas that could benefit the most from additional studies.

9 February 2023 in Life
Verified
Journal Article
Open access
PDF file
RGRaluca Roxana Grigorescu
Raluca Roxana Grigorescu
IHIoana Alexandra Husar-Sburlan
Ioana Alexandra Husar-Sburlan
GRGeorgiana Florentina Rosulescu
Georgiana Florentina Rosulescu
ABAnca Bobirca
Anca Bobirca
RCRazvan Claudiu Cerban
Razvan Claudiu Cerban
FMFlorescu Madalina
Florescu Madalina
In recent years, we have faced an increasing incidence of inflammatory bowel disease (IBD), especially among young people, affecting them during their reproductive years. The paucity of data and reduced knowledge regarding the evolution of the disease during pregnancy and the adverse effects of the therapy on the mother and infant increase voluntary childlessness in this group of patients. Depending on the type of IBD, severity and surgical or medical management, this can negatively affect the pregnancy. C-sections and the risk of low-birth-weight babies are higher in women with IBD, independent of active/inactive disease, while preterm birth, stillbirth and miscarriage are associated with disease activity. In the last period, medicinal therapy has evolved, and new molecules have been developed for better control of the lesions, but the effect on pregnancy and breastfeeding is still controversial. We conducted this review by studying the literature and recent research in order to have a better image of the practical management of IBD during pregnancy.